Advisory Services Network’s Xeris Biopharma Holdings XERS Stock Holding History

Advisory Services Network’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.8K	Buy	+1,000	New	+$6.63K	﹤0.01%	3786
2025 Q4	–	Sell	-1,000	Closed	-$8.14K	–	4264
2025 Q3	$8.14K	Buy	+1,000	New	+$6.64K	﹤0.01%	3362
2021 Q3	–	Sell	-45	Closed	–	–	3248
2021 Q2	$0	Buy	+45	New	+$172	﹤0.01%	3654
2020 Q4	–	Sell	-315	Closed	-$2K	–	3754
2020 Q3	$2K	Buy	+315	New	+$1.26K	﹤0.01%	3211

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's XERS Position: Q1 2026 in Review

Advisory Services Network opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 1,000 shares worth $5.8K. The stake represents ﹤0.01% of the portfolio and ranks #3786 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in XERS as recently as Q3 2025.

Advisory Services Network first reported a position in XERS in Q3 2020 and has held it in 4 quarters since. The position peaked at $8.14K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

Advisory Services Network held 1,000 shares of Xeris Biopharma Holdings worth $5.8K as of Q1 2026.
Xeris Biopharma Holdings was a new Advisory Services Network position in Q1 2026.
Xeris Biopharma Holdings made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3786 holding.
Advisory Services Network first reported a position in Xeris Biopharma Holdings in Q3 2020 and has held it in 4 quarters since.
Advisory Services Network's Xeris Biopharma Holdings position peaked at $8.14K in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.